Filing Details

Accession Number:
0001104659-20-033114
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-13 16:07:45
Reporting Period:
2020-01-01
Accepted Time:
2020-03-13 16:07:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1429260 Fortress Biotech Inc. FBIO Pharmaceutical Preparations (2834) 205157386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1772558 Kevin Lorenz C/o Fortress Biotech, Inc.
2 Gansevoort Street, 9Th Floor
New York NY 10014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2020-01-01 50,000 $0.00 164,582 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. One-third of the shares will vest on each of January 1, 2021, 2022 and 2023, subject to continued service.
  2. Includes 34,582 shares owned by Mr. Lorenz prior to his appointment to the Company's board in August 2019.